JXN:NYSEJackson Financial Inc. Analysis
Data as of 2026-04-12 - not real-time
$101.62
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Jackson Financial trades below its 20‑day and 50‑day simple moving averages, with the price hovering just above the 200‑day SMA, indicating a short‑term pullback within a longer‑term flat backdrop. The RSI sits in the low‑mid 40s and the MACD histogram has turned positive, giving a modest bullish signal despite decreasing volume and a neutral trend classification. Valuation metrics are strikingly cheap – forward P/E under 4 versus an industry average above 17, price‑to‑book below 1, and a dividend yield above 3% backed by a payout ratio under 50% and solid free cash flow. Fundamentally, the company posted double‑digit revenue growth in annuity sales, a strong cash position that matches its debt load, and a recent earnings turnaround highlighted in the news, while profitability remains thin.
The stock’s volatility is high (over 35% 30‑day) and beta exceeds 1.3, suggesting sensitivity to market swings, yet geographic exposure is limited to the United States, reducing currency concerns. Analyst consensus remains a “hold” with median price targets near $119, implying roughly 15‑20% upside from the current level. Overall, the blend of deep value multiples, improving earnings outlook, and a reliable dividend makes JXN a candidate for investors comfortable with medium‑term price recovery and willing to navigate short‑term technical weakness.
The stock’s volatility is high (over 35% 30‑day) and beta exceeds 1.3, suggesting sensitivity to market swings, yet geographic exposure is limited to the United States, reducing currency concerns. Analyst consensus remains a “hold” with median price targets near $119, implying roughly 15‑20% upside from the current level. Overall, the blend of deep value multiples, improving earnings outlook, and a reliable dividend makes JXN a candidate for investors comfortable with medium‑term price recovery and willing to navigate short‑term technical weakness.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below short‑term SMAs indicating near‑term weakness
- Decreasing volume and neutral trend
- Attractive dividend yield providing downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervaluation relative to peers and forward earnings
- Record annuity sales growth and improving earnings outlook
- Sustainable dividend supported by strong cash flow
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Durable business model in life insurance and annuities
- Consistent cash generation with manageable debt
- Long‑term upside potential from valuation gap and sector tailwinds
Key Metrics & Analysis
Financial Health
Revenue Growth718.80%
Profit Margin0.40%
P/E Ratio3.9
ROE0.71%
ROA0.12%
Debt/Equity55.12
P/B Ratio0.7
Op. Cash Flow$5.8B
Free Cash Flow$1.7B
Industry P/E17.1
Technical Analysis
TrendNeutral
RSI42.3
Support$100.73
Resistance$109.60
MA 20$104.30
MA 50$110.09
MA 200$101.26
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09
Valuation
Fair Value$899.68
Target Price$122.00
Upside/Downside20.06%
GradeUndervalued
TypeBlend
Dividend Yield3.54%
Risk Assessment
Beta1.31
Volatility37.65%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.